Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb (BMY) has launched a ...
Bristol Myers Squibb is axing another big bet from the Caforio era, terminating a deal for Agenus’ TIGIT bispecific antibody three years after paying $200 million to buy into the program. Agenus ...
BMS, an independent insurance and reinsurance broker, has announced the appointment of Charlie Emkes to the newly created ...
Bristol Myers Squibb (BMS) plans to buy out its partner in developing the blockbuster multiple myeloma drug Abecma ® (idecabtagene vicleucel), by agreeing to acquire 2seventy bio for approximately ...
[Editor’s note: The hacker requested that we remove the image for legal reasons, so it’s blurry now. We hope all’s well!] Lithium technology has ushered in a new era of batteries with exceptionally ...
Bristol Myers Squibb’s examination into whether its heart med Camzyos can spark improvements in patients with non-obstructive hypertrophic cardiomyopathy (nHCM) turned out to be a conclusive failure, ...
On April 25, I wrote about an appeal Jason Hughes made on Twitter. The Tesla Hacker urged people not to reset their Model S units with BMS_u029 or BMS_u018 error ...
BMS Group has announced a strategic partnership with Berns Brett India, signalling its expansion into the Indian market, with the local entity set to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback